Skip to main content
Clinical Trials/ACTRN12622000056796
ACTRN12622000056796
Recruiting
未知

Feasibility study for a novel approach to delivery of breakthrough analgesics in palliative care

Dr Michael Briffa0 sites30 target enrollmentJanuary 18, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Palliative Care
Sponsor
Dr Michael Briffa
Enrollment
30
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 18, 2022
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Michael Briffa

Eligibility Criteria

Inclusion Criteria

  • Staff\- employed as a Registered Nurse or Medical Officer at Flinders Medical Centre and working at Laurel Hospice
  • Patients \- Admitted patients to the Laurel Hospice receiving intermittent analgesics via subcutaneous or intravenous injection who are over 18\.

Exclusion Criteria

  • Patients not receiving breakthrough analgesia
  • Patient receiving less than four breakthrough analgesia doses per 24 hours.

Outcomes

Primary Outcomes

Not specified

Similar Trials